FDA Adverse Event Injury Summary report: N

ULTRASOFT LANCING DEV

MDR report key: 1760363 · Received July 18, 2010

Report

Report Number
2939301-2010-05734
Event Type
Injury
Date Received
July 18, 2010
Date of Event
July 7, 2010
Report Date
July 7, 2010
Manufacturer
LIFESCAN, INC.
Product Code
NBW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.SERIAL NUMBER: NOT PROVIDED.LOT NUMBER: NOT PROVIDED.

Description of Event or Problem · 1

ON (B)(6) 2010, THE LAY USER/PATIENT CONTACTED LIFESCAN TO REPORT THE LANCET WITH THE ONE TOUCH ULTRASOFT LANCING DEVICE WOULD NOT FULLY PENETRATE THE SKIN. THE SR. MEDICAL SURVEILLANCE SPECIALIST WAS ABLE TO CLASSIFY THE COMPLAINT BASED ON THE INFORMATION ORIGINALLY PROVIDED. ON (B)(6) 2010 AT 3:00 PM, THE PATIENT NOTED THE REPORTED LANCING DEVICE'S LANCET WOULD NOT FULLY PENETRATE HER SKIN; SHE WAS UNABLE TO OBTAIN A BLOOD GLUCOSE READING. THREE HOURS AFTERWARDS, THE PATIENT EXPERIENCED THE SYMPTOMS OF SHAKING, SWEATING AND SLURRED SPEECH. THE PATIENT CONSUMED MORE FOOD AND/OR DRINK; SHE DID NOT SEEK ANY MEDICAL ATTENTION OR TREATMENT. THE PATIENT MANAGES HER DIABETES WITH VICTOZA (LIRAGLUTIDE), NOVOLOG INSULIN AND LANTUS INSULIN. THE LANCING DEVICE WAS REPLACED. THE PATIENT ALLEGEDLY SUFFERED SYMPTOMS SUGGESTING SEVERE HYPOGLYCEMIA AFTER SHE WAS UNABLE TO OBTAIN A BLOOD SAMPLE FOR GLUCOSE TESTING DUE TO THE LANCING DEVICE ISSUE, AND RECEIVED TREATMENT WITH FOOD. THEREFORE THIS COMPLAINT IS BEING REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ULTRASOFT LANCING DEV GLUCOSE MONITORING SYS/KIT NBW LIFESCAN, INC.

Patients

Seq Age Sex Outcome Treatment
1 41 YR Life Threatening| R